EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers

Mayank Aranke, Cynthia T Pham, Melis Yilmaz, Jason K Wang, Vwaire Orhurhu, Daniel An, Elyse M Cornett, Alan David Kaye, Anh L Ngo, Farnad Imani iD, Reza Farahmand Rad iD, Giustino Varrassi iD und 2 weitere

Anesthesiology and Pain Medicine · 24.02.2021 · 11 (1)

DOI: 10.5812/aapm.112832 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Anesthesiology and Pain Medicine, online erschienen am 24.02.2021. Verfasst von Mayank Aranke und 13 weiteren Autor:innen. Beteiligte Einrichtung: Texas Tech University Health Sciences Center, School of Medicine, Harvard TH Chan School of Public Health, Lubbock, Texas, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: In the US, an estimated 1 - 2% of chronic venous insufficiency (CVI) patients (of 6 - 7 million nationwide) develop at least one venous stasis ulcer (VSU) during their illness. Of these, approximately 40% develop subsequent ulcers, making VSU prognostically poor. Current management of VSU is costly, with poor prognosis, high recurrence rate, inadequate pain management, and significantly reduced quality of life (QoL). Topical volatile anesthetic agents, such as sevoflurane, offer improved pain relief and symptom control in patients suffering from chronic VSU. The immediate impact of topical sevoflurane in reducing pain associated with ulcer bed debridement has several implications in improving the quality of life in patients with CVI induced ulcers and in the prognosis and healing of the ulcers. This review summarizes a topical formulation of a volatile anesthetic and its implications for the management of VSUs.

Schlagwörter

Stichwörter der Autor:innen

AnalgesiaPainSevofluraneVenous InsufficiencyVenous Stasis UlcerWound Management

Autor:innen und Institutionen

  • Texas Tech University Health Sciences Center, School of Medicine, Harvard TH Chan School of Public Health, Lubbock, Texas, USA.
  • Georgetown University School of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Massachusetts General Hospital, Boston, MA, USA.
  • LSU Health Shreveport, Department of Anesthesiology, Shreveport, LA, USA.
  • Pain Specialty Group, Portsmouth, NH, USA.

ORCID-Profile: Farnad Imani, Reza Farahmand Rad, Giustino Varrassi, Omar Viswanath, Ivan Urits

Zitieren

APA

Aranke, M., Pham, C. T., Yilmaz, M., Wang, J. K., Orhurhu, V., An, D., Cornett, E. M., Kaye, A. D., Ngo, A. L., Imani, F., Farahmand Rad, R., Varrassi, G., Viswanath, O., & Urits, I. (2021). Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers. Anesthesiology and Pain Medicine, 11(1). https://doi.org/10.5812/aapm.112832

Vancouver

Aranke M, Pham CT, Yilmaz M, Wang JK, Orhurhu V, An D, et al. Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers. Anesthesiology and Pain Medicine. 2021;11(1). doi:10.5812/aapm.112832

BibTeX
@article{Aranke2021,
  author = {Aranke, Mayank and Pham, Cynthia T and Yilmaz, Melis and Wang, Jason K and Orhurhu, Vwaire and An, Daniel and Cornett, Elyse M and Kaye, Alan David and Ngo, Anh L and Imani, Farnad and Farahmand Rad, Reza and Varrassi, Giustino and Viswanath, Omar and Urits, Ivan},
  title = {Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers},
  journal = {Anesthesiology and Pain Medicine},
  year = {2021},
  volume = {11},
  number = {1},
  doi = {10.5812/aapm.112832}
}
Kostenlos starten →